
Sign up to save your podcasts
Or


This is a discussion on the recent CREDENCE trial for canagliflozin in diabetics with nephropathy.
By Dr Casey Parker4.8
55 ratings
This is a discussion on the recent CREDENCE trial for canagliflozin in diabetics with nephropathy.

26,240 Listeners

1,874 Listeners

548 Listeners

6 Listeners

259 Listeners

315 Listeners

1,829 Listeners